Facebook Linkedin Twitter
Inside Precision Medicine NCI Taps Protagen Biomarker Technology for Immuno-Oncology Studies

Immune system diseases

Source: extender01/Getty Images
News & Features

NCI Taps Protagen Biomarker Technology for Immuno-Oncology Studies

Inside Precision Medicine Staff Writer -
0
This Korhonen map shows how novel proprietary biomarkers enable differentiation of autoimmune diseases. Identification of patient subsets provides specific targets for therapeutic development and CDx; this increases the probability of successful approvals of novel drugs and therapies.
News & Features

Snapshot: The Challenges and Opportunities of Personalizing Treatment for Autoimmune Diseases

Georg Lautscham -
0
Figure 1. In vitro (IVDs) diagnostics can help to tackle a lack of diagnostic resolution. Without the proper tools
Molecular Dx

Case Study: From Diagnostics to Companion Diagnostics: Targeting Autoimmune Diseases

Peter Schulz-Knappe -
0
Two hands viewed in X-ray format showing red areas of inflammation around the joints to indicate arthritis or rheumatic disease
Molecular Dx

Want to Personalize Autoimmune Treatments? Improve Diagnostics First

Chris Anderson -
0
Clinical OMICs Magazine Volume 1, Issue No. 1
News & Features

Clinical OMICs Magazine Volume 1, Issue No. 1

Inside Precision Medicine Staff Writer -
0
1...111213Page 13 of 13

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine